国际生殖健康/计划生育 ›› 2014, Vol. 33 ›› Issue (3): 232-235.

• 论著 • 上一篇    下一篇

不同hCG日判定标准对IVF/ICSI-ET治疗结局的影响

李艳辉,高颖,耿育红,陈莉娟,刘琳,陈春艳   

  1. 430022 武汉,华中科技大学附属协和医院生殖中心
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2014-05-15 发布日期:2014-05-15

Effects of Different Criteria of hCG Administration on IVF/ICSI-ET Outcomes

LI Yan-hui,GAO Ying,GENG Yu-hong,CHEN Li-juan,LIU Lin,CHEN Chun-yan   

  1. Reproductive Center,Union Hospital,Huazhong University of Science and Technology,Wuhan 430022,China
  • Received:1900-01-01 Revised:1900-01-01 Published:2014-05-15 Online:2014-05-15

摘要: 目的:探讨强调主导卵泡直径大小和强调卵泡均称性2种不同的注射人绒毛膜促性腺激素(hCG)日标准对体外受精/胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)治疗结局的影响。方法:采用前瞻性随机对照研究,将2013年1月—3月在华中科技大学附属协和医院生殖中心行IVF/ICSI-ET助孕的不孕患者随机分为A、B组,A组采用强调主导卵泡直径大小的hCG日标准,B组采用强调卵泡均称性的hCG日标准;比较2组患者在各临床及实验室指标上的差异。结果:B组患者的平均促性腺激素(Gn)使用时间、hCG日孕酮和雌二醇浓度、平均获卵数、平均成熟卵数、成熟卵率等均高(大)于A组(P<0.05)。虽然2组患者可利用胚胎数及冷冻胚胎数差异并无统计学意义(P>0.05),但B组患者的临床妊娠率显著低于A组(42.19% vs. 54.22%, χ2=4.18,P=0.04),且B组卵巢过度刺激综合征(OHSS)发生率显著高于A组(10.77% vs. 5.86%,χ2=4.07,P=0.04)。结论:强调卵泡发育均称性的hCG日注射标准,在IVF/ICSI-ET有效性及安全性上并不优于传统的侧重主导卵泡大小的hCG日标准。

关键词: 绒毛膜促性腺激素, 受精, 体外, 精子注射, 细胞质内, 胚胎移植, 超排卵, 妊娠结局

Abstract: Objective:To explore the effects of two criteria of hCG administration on the clinical outcomes of IVF/ICSI-ET. These criteria were individually based on the follicle diameter and the follicle symmetry. Methods:It′s a prospective randomized study in our hospital reproductive center. IVF/ICSI-ET patients were randomly divided into two groups from Jan 2013 to Mar 2013. The criterion of hCG administration in Group A was based on the follicle diameter,while Group B on the follicle symmetry. Clinical and laboratory outcomes were then compared. Results:The average days of Gn, serum levels of progesterone and estradiol on the hCG day,the average number of matured eggs, and the rate of matured oocytes of group B were significantly higher than those of group A(P<0.05). There was not significant difference in the numbers of frozen embryos and good quality embryos between the two groups. However,the clinical pregnancy rate of group B was significantly lower than that of group A(42.19% vs. 54.22%, χ2=4.18,P=0.04), and the incidence of OHSS in group B significantly higher than that of group A(10.77% vs. 5.86%, χ2=4.07,P=0.04). Conclusions:The criterion based on the uniform size of follicular is not superior to the traditional criterion focused on the dominant follicle size in the efficacy and safety of IVF/ICSI-ET treatment.

Key words: Chorionic gonadotropin, Fertilization in vitro, Sperm injections, intracytoplasmic, Embryo transfer, Superovulation, Pregnancy outcome